Furthermore, M-S-Exo derived from CSCs of metastatic CCRCC patients has stronger fusion and contains a high proportion of CD103+ exosomes, which presents a strong EMT regulatory effect. This evidence concerns the gene ITGAE and nonpapillary renal cell carcinoma.